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of collapse.2–4 Minimising the time above the 
critical threshold for cell damage decreases 
the extent of tissue and organ damage within 
the body. Demartini and colleagues showed 
that, when body temperature was reduced 
below the critical threshold in 274 individuals 
who had succumbed to EHS, there was 100% 
survival without any known sequelae.5 Second, 
the mode of body cooling should be such that 
the cooling rate is optimal (>0.15°C/min) for 
EHS treatment.6 Alternative options such as 
tarp-assisted cooling have been shown to be 
just as effective as cold-water immersion and 
can be implemented with ease.7,8
To optimise the treatment and care of 
individuals suffering EHS, it is essential 
that patient care take an interdisciplinary 
approach. Coordinating care between 
onsite medical providers (for example, 
athletic trainers, other sports medicine 
professionals), emergency medical services, 
and primary care physicians allows for a 
seamless transition of care between medical 
providers to optimise patient outcomes.
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Minimising iatrogenic 
nerve injury in primary 
care
Wallis and colleagues did not find any cases 
of nerve injury relating to contraceptive 
implant insertion/removal in the New 
Zealand claims dataset. However, such 
injuries were first reported more than 
20 years ago with the 6-rod Norplant and 
frequently lead to litigation. I have seen 11 
such cases in my medicolegal practice. The 
site for such injuries is the sulcus between 
biceps and triceps in the upper arm, 8–10 cm 
above the medial epicondyle. Three nerves 
run in a neurovascular bundle just below 
the fascia: the median, ulnar, and medial 
cutaneous nerve of the forearm. All three 
have been injured at the time subdermal 
implant procedures are performed.2–6 
These injuries continue to happen, despite 
the recommended site for insertion having 
been moved away from the sulcus in 
2008. The injuries generally occur when 
blind instrumentation is performed during 
attempts to remove implants that are situated 
deeply or are tethered. Some women have 
suffered permanent neurological deficit, 
despite undergoing neurolysis procedures. 
In my view, routine removals should only be 
carried out by the ‘pop-out’ technique (for a 
nice demonstration of this, see this videoclip: 
bjgplife.com/popout). Attempts at removal 
should be abandoned if not straightforward 
or if the woman complains of sensory 
symptoms. 
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Corrections
Research by Shephard EA and Hamilton WT, 
Selection of men for investigation of possible 
testicular cancer in primary care: a large case–
control study using electronic patient records. Br 
J Gen Pract 2018; DOI: https://doi.org/10.3399/
bjgp18X697949 showed an inaccuracy in the print 
version. The printed version states ‘Testicular 
swelling alone has a PPV for cancer just below the 
3% threshold, but when combined with testicular, 
groin or abdominal pain, particularly in men aged 
>50 years, the likelihood of cancer is considerably 
greater.’ The corrected version should read ‘A 
testicular lump alone has a PPV for cancer just below 
the 3% threshold, but when combined with testicular 
swelling, pain or abdominal pain in men <50 years, 
the likelihood of cancer is considerably greater.’ 
This appears in the grey box at top of print abridged 
version only. The online version is correct.
DOI: https://doi.org/10.3399/bjgp18X698513
* * * * *
Research by the DAMASK Trial Team, Cost-
effectiveness of magnetic resonance imaging of 
the knee for patients presenting in primary care. 
Br J Gen Pract 2008; DOI: https://doi.org/10.3399/
bjgp08X342660 showed mean QALYs over 24 months 
as difference = 0.050 and 95% CI = 0.025 to 0.118 in 
the Abstract and Table 4. The lower CI is missing a 
minus, and it should read –0.025 to 0.118, around 
a difference of 0.050. The online version has been 
corrected.
DOI: https://doi.org/10.3399/bjgp18X698525
* * * * *
In the study by Davies J et al, Long-term 
benzodiazepine and Z-drugs use in the UK: a survey 
of general practice. Br J Gen Pract 2018; DOI: 
https://doi.org/10.3399/bjgp17X691865, the data for 
the general population of NHS patients in 2014 were 
for England only, rather than the UK as a whole. The 
correct article title is ‘Long-term benzodiazepine 
and Z-drugs use in England: a survey of general 
practice’, and there are changes throughout the 
article to reflect this. The online version has been 
corrected. 
DOI: https://doi.org/10.3399/bjgp18X698837
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